Zella
Casey Zella, Huntersville, NC US
Patent application number | Description | Published |
---|---|---|
20150276511 | METHOD OF IDENTIFYING AND REDUCING LATERAL FORCE OF A COIL SPRING - A method of monitoring lateral force of a coil spring having a body and opposing end coils is disclosed. A fixture includes a base defining a planar surface with a shaft that extends from said planar surface at a normal angle to said planar surface. An axis defined by the coil spring is aligned with the shaft. Angular displacement from the shaft of an end coil is measured, and the angular displacement is correlated with a lateral force value. | 10-01-2015 |
Davide Zella, Cantonsville, MD US
Patent application number | Description | Published |
---|---|---|
20110183917 | P53 Activator Peptides - The present invention relates to novel polypeptides that activate p53, and the polynucleotides encoding these p53 activator peptides. The present invention also relates to pharmaceutical compositions comprising the p53 activator peptides as well as methods of treating abnormal conditions, such as malignant tumors, with the methods comprising administering the pharmaceutical compositions of the present invention to a subject in need of treatment thereof. | 07-28-2011 |
Garrett Zella, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20120003158 | Biomarkers for Inflammatory Bowel Disease and Methods Using the Same - The present invention provides various biomarkers of inflammatory bowel disease, including biomarkers for Crohn's disease and biomarkers for Ulcerative colitis. The present invention also provides various methods of using the biomarkers, including methods for diagnosis of inflammatory bowel disease, methods for distinguishing between inflammatory bowel diseases, methods of determining predisposition to inflammatory bowel disease, methods of monitoring progression/regression of inflammatory bowel disease, methods of assessing efficacy of compositions for treating inflammatory bowel disease, methods of screening compositions for activity in modulating biomarkers of inflammatory bowel disease, methods of treating inflammatory bowel disease, as well as other methods based on biomarkers of inflammatory bowel disease. | 01-05-2012 |
Julia Zella, Horicon, WI US
Patent application number | Description | Published |
---|---|---|
20090004133 | Methods and compositions for phosphate binding - The present invention provides improved methods and compositions for therapeutically controlling and/or reducing serum phosphate levels in animals and mammalian patients. The methods comprise administering to the patient an amount of a dendrimer composition effective to prevent absorption of substantial amounts of phosphate from the patient's GI tract. In a preferred version, a dose of between 2.5 and 15 grams per day is effective to prevent over 80% of phosphate present in the patient's GI tract from being absorbed. The dendrimer composition may comprise a hydrocitrate, hydrochloride, hydrobromide, hydroacetate or hydroanionic form. | 01-01-2009 |
Julia B. Zella, Horicon, WI US
Patent application number | Description | Published |
---|---|---|
20140005152 | Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism | 01-02-2014 |
20140187522 | Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism - Disclosed are methods of administering 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D | 07-03-2014 |